Feb 7, 2022
Today we’re jumping into the pharmaceutical industry with Phil DeSantis. Phil brings over fifty years of executive experience with firms such as Merck, Squibb and J&J. He is also the past Chair of the Parenteral Drug Association Science Advisory Board and is active in the International society for pharmaceutical engineering. He has published numerous articles, technical reports and books in the area of pharmaceutical engineering and is the co-editor of the forthcoming book Handbook of Validation of Pharmaceutical processes.
Phil and Kelly breakdown "Big Pharma" and shed some light on misconceptions about the pharmaceutical industry. They also talk about the balance between innovation and expense, how the pharmaceutical industry intersects with the larger conversation of healthcare policy and the effect of over regulation.